Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Market Cap : 2.142B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.206B |
| November 11, 2026 | 2.196B |
| November 10, 2026 | 2.188B |
| November 09, 2026 | 2.212B |
| November 06, 2026 | 1.949B |
| November 05, 2026 | 1.869B |
| November 04, 2026 | 1.901B |
| November 03, 2026 | 2.097B |
| November 02, 2026 | 2.008B |
| October 30, 2026 | 2.123B |
| October 29, 2026 | 2.362B |
| October 28, 2026 | 2.380B |
| October 27, 2026 | 2.216B |
| October 26, 2026 | 2.109B |
| October 23, 2026 | 2.130B |
| October 22, 2026 | 2.062B |
| October 21, 2026 | 2.182B |
| October 20, 2026 | 1.954B |
| October 19, 2026 | 1.825B |
| October 16, 2026 | 1.754B |
| October 15, 2026 | 1.903B |
| October 14, 2026 | 1.760B |
| October 13, 2026 | 1.632B |
| October 12, 2026 | 1.682B |
| October 09, 2026 | 1.753B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.798B |
| October 07, 2026 | 1.927B |
| October 06, 2026 | 2.238B |
| October 05, 2026 | 2.646B |
| October 02, 2026 | 2.384B |
| October 01, 2026 | 2.252B |
| September 30, 2026 | 2.364B |
| September 29, 2026 | 2.266B |
| September 28, 2026 | 2.263B |
| September 25, 2026 | 2.276B |
| September 24, 2026 | 2.304B |
| September 23, 2026 | 2.230B |
| September 22, 2026 | 2.305B |
| September 21, 2026 | 2.432B |
| September 18, 2026 | 2.418B |
| September 17, 2026 | 2.221B |
| September 16, 2026 | 2.039B |
| September 15, 2026 | 1.995B |
| September 14, 2026 | 1.942B |
| September 11, 2026 | 1.935B |
| September 10, 2026 | 1.927B |
| September 09, 2026 | 2.009B |
| September 08, 2026 | 2.078B |
| September 04, 2026 | 2.137B |
| September 03, 2026 | 2.121B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Personalis, Inc. | 1.702B |
| 10X Genomics, Inc. | 7.650B |
| Champions Oncology, Inc. | 65.14M |
| Medpace Holdings, Inc. | 18.23B |
| Avantor, Inc. | 10.52B |
Market Cap Related Metrics
| PS Ratio | 19.64 |
| PEG Ratio | -0.1366 |
| Price to Book Value | 7.052 |
| Price | 30.83 |
| Earnings Yield | -2.61% |
| PEGY Ratio | -0.1366 |